Abstract
Summary
Addition of aureomyein to human plasma in vitro produces a significant decrease in the heparin concentration. Aureomyein administered by the intravenous route lowered the coagulation time of the blood of 10 of 11 patients.
Get full access to this article
View all access options for this article.